Stockholders' Deficit - Schedule of Stock Option Activity (Details) |
3 Months Ended |
---|---|
Mar. 31, 2018
$ / shares
shares
| |
Equity [Abstract] | |
Number of Options Outstanding, beginning balance | shares | 38,478 |
Number of Options Granted | shares | |
Number of Options Expired | shares | |
Number of Options Exercised | shares | |
Number of Options Options Outstanding, ending balance | shares | 38,478 |
Number of Options Options Exercisable | shares | 32,922 |
Weighted average exercise price, Outstanding beginning | $ 2,072.75 |
Weighted average exercise price, Granted | |
Weighted average exercise price, Expired | |
Weighted average exercise price, Forfeited | |
Weighted average exercise price, Exercised | |
Weighted average exercise price, Outstanding, ending balance | 2,072.75 |
Weighted average exercise price, Exercisable | $ 2,373.16 |
Weighted average contractual term (Yrs.), beginning | 8 years 3 months 29 days |
Weighted average contractual term (Yrs.), ending | 8 years 3 months 29 days |
X | ||||||||||
- Definition Weighted average contractual term, Options Outstanding, beginning balance. No definition available.
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- Definition The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Number of options or other stock instruments for which the right to exercise has lapsed under the terms of the plan agreements. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Net number of share options (or share units) granted during the period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Number of options outstanding, including both vested and non-vested options. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Weighted average price at which option holders acquired shares when converting their stock options into shares. No definition available.
|
X | ||||||||||
- Definition Weighted average price at which grantees could have acquired the underlying shares with respect to stock options of the plan that expired. No definition available.
|
X | ||||||||||
- Definition Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated. No definition available.
|
X | ||||||||||
- Definition Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options. No definition available.
|
X | ||||||||||
- Definition Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Number of share options (or share units) exercised during the current period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|